Sanderling Ventures

Sanderling Ventures operates as a specialized venture capital firm establishing new biomedical companies. It targets significant market opportunities, including small molecule therapeutics, medical devices, and diagnostics. The firm employs an active management model, providing seed and early-stage funding alongside strategic and operational guidance to advance novel healthcare solutions.

Founded in 1979, Sanderling is among the oldest investment firms exclusively dedicated to the biomedical sector. Its inception stemmed from the insight that impactful ventures thrive through close, collaborative partnerships between experienced investors and innovative entrepreneurs, a belief guiding its approach.

Sanderling supports early-stage biomedical companies, offering capital and expert oversight for growth and market entry. Its vision centers on identifying and advancing groundbreaking medical technologies addressing critical unmet needs, bringing innovative solutions to market. The firm aims to generate enduring value by ensuring portfolio success, contributing to human health.